DC21506 |
PFE-360 |
PFE-360 is a novel potent, selective, brain-penetrating LRRK2 inhibitor with IC50 of 3 nM. |
|
DC5025 |
PFI-1 (PF-6405761)
Featured
|
PFI-1 is a selective BET (bromodomain-containing protein) inhibitor for BRD4 with IC50 of 0.22 μM. |
|
DC7679 |
(R)PFI-2 HCl
Featured
|
PFI-2 is a novel potent and selective SETD7 histone lysine methyltransferase inhibitor with IC50 ~2 nM. It has > 100-fold selectivity over other methyltransferases and other non-epigenetic targets. |
|
DC7649 |
PFI-3
Featured
|
PFI-3 is a novel potent, selective and cell permeable inhibitor of SMARCA4 and PB1(5) bromodomains with IC50 ~ 89 nM and 48 nM respectively. |
|
DC8291 |
PFI-4
Featured
|
PFI-4 is a potent and selective BRPF1 bromodomain inhibitor (IC50 = 80 nM). |
|
DC8026 |
PFK-015
Featured
|
PFK-015 is an effective inhibitor of PFKFB3 with IC50 of 110 nM (recombinant PFKFB3) and inhibits PFKFB3 activity in cancer cells with IC50 of 20 nM. |
|
DC10451 |
PFK158
Featured
|
PFK-158 is a potent and selective inhibitor of PFKFB3 that is currently being investigated in a phase I study in patients with advanced solid malignancies. |
|
DC23255 |
PfKRS1 inhibitor 5 |
PfKRS1 inhibitor 5 is a potent, selective, oral inhibitor of P. falciparum lysyl-tRNA synthetase (PfKRS1) with IC50 of 15 nM, displays >100-fold selectivity over Human KRS (HsKRS, IC50=1.8 uM). |
|
DC21665 |
PFM01
Featured
|
PFM01 (SML1735) is a small molecule that specifically inhibits endonuclease, but not exonuclease activity of MRE11, inhibits dsDNA end resection in A549 cells with IC50 of 50-75 uM, blocks the ssDNA-binding path toward the catalytic metal ions and disrupt |
|
DC21666 |
PFM39 |
PFM39 (SML1839) is a small molecule that specifically inhibits exonuclease activity of MRE11, binds in the active site similar to mirin, inhibits dsDNA end resection in A549 cells with IC50 of 50-75 uM, inhibits HR without significantly increasing NHEJ.. |
|
DC20496 |
PGC-1α activator C80 |
PGC-1α activator C80 is a potent PGC-1α acetylation activator with AC50 of 3.1 uM, induces Pck1 and G6pc expression with AC50 of 11.9 uM and 12.8 uM, reduces glucose production in hepatocytes.. |
|
DC12552 |
PGN9856
Featured
|
PGN-9856 (PGN9856) is a novel potent, selective prostaglandin EP2 receptor agonist with pKi of > 8.3, shows higi selectivity over EP1 , EP3 , EP4 , DP, FP, IP and TP receptors; displays a potency (pEC50 >8.5) and a maximal response (increase in cAMP) comp |
|
DC20007 |
P-gp inhibitor 1 |
P-gp inhibitor 1 is a novel inhibitor reversing P-glycoprotein-mediated multidrug resistance. |
|
DC20498 |
PG-S3-001 |
PG-S3-001 is a small molecule STAT3 inhibitor that binds to STAT3 protein potently with Kd of 324 nM by surface plasmon resonance. |
|
DC10794 |
PH-002
Featured
|
PH-002 is a small-molecule structure corrector,inhibitor of apolipoprotein (apo) E4 intramolecular domain interaction,a potent candidate drug for the treament of AD(Alzheimer disease) |
|
DC7727 |
PH-797804
Featured
|
PH-797804 is a potent and selective p38 inhibitor with IC50 of 26 nM. |
|
DC7230 |
PHA-665752
Featured
|
PHA-665752 is a potent, selective and ATP-competitive c-Met inhibitor with IC50 of 9 nM, >50-fold selectivity for c-Met than RTKs or STKs. |
|
DC5111 |
PHA-680632
Featured
|
PHA-680632 is potent inhibitor of Aurora A, Aurora B and Aurora C with IC50 of 27 nM, 135 nM and 120 nM, respectively. It has 10- to 200-fold higher IC50 for FGFR1, FLT3, LCK, PLK1, STLK2, and VEGFR2/3. |
|
DC9391 |
PHA-767491 (hydrochloride) |
PHA-767491 (CAY10572) Hcl is a potent, ATP-competitive dual Cdc7/Cdk9 inhibitor with IC50 values of 10/34 nM. |
|
DC8025 |
CAY10572(PHA-767491)
Featured
|
PHA-767491 (CAY10572) is a potent, ATP-competitive dual Cdc7/Cdk9 inhibitor with IC50 values of 10/34 nM. |
|
DC4123 |
PHA-793887
Featured
|
PHA-793887 is a novel and potent inhibitor of CDK2, CDK5 and CDK7 with IC50 of 8 nM, 5 nM and 10 nM, respectively. |
|
DC7231 |
PHA-848125(Milciclib)
Featured
|
PHA-848125(Milciclib) is a potent, ATP-competitive CDK inhibitor for CDK2 with IC50 of 45 nM; >3-fold more selective for CDK2 than CDK1, 2, 4, 5, and 7. |
|
DC9752 |
PHCCC
Featured
|
PHCCC is a Group I metabotropic glutamate receptor antagonist (IC50 ~ 3 μM). |
|
DC8955 |
Phenacetin |
Phenacetin is a non-opioid analgesic without anti-inflammatory properties. |
|
DC8999 |
Phenazopyridine hydrochloride |
Phenazopyridine Hcl is a chemical, which has a local analgesic effect, often used to alleviate the pain, irritation, discomfort, or urgency caused by urinary tract infections, surgery, or injury to the urinary tract. |
|
DC8145 |
Phen-DC 3 |
Phen-DC 3|Phen-DC-3,Phen-DC3|DC Chemicals |
|
DC8990 |
Phenformin hydrochloride |
Phenformin, an anti-diabetic drug, has demonstrated antitumor activity both in vitro and in vivo. |
|
DCAPI1358 |
Phenindione(Rectadione) |
Phenindione(Rectadione) |
|
DC9083 |
Pheniramine Maleate |
Pheniramine Maleate ia an antihistamine and vasoconstrictor. |
|
DC1110 |
Phenprocoumon (Marcumar) |
Phenprocoumon is closely related to warfarin and is an anticoagulant drug used to thin the blood, or stop it from clotting. |
|